These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]
9. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Hoitsma AJ; Hilbrands LB Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494 [TBL] [Abstract][Full Text] [Related]
10. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Brann WM; Bennett LE; Keck BM; Hosenpud JD J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582 [TBL] [Abstract][Full Text] [Related]
11. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040 [TBL] [Abstract][Full Text] [Related]
12. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Marin M; Renoult E; Bondor CI; Kessler M Transplant Proc; 2005 May; 37(4):1851-6. PubMed ID: 15919484 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Ye X; Kuo HT; Sampaio MS; Jiang Y; Reddy P; Bunnapradist S Transplantation; 2010 Jun; 89(12):1526-32. PubMed ID: 20431437 [TBL] [Abstract][Full Text] [Related]
15. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine. Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255 [TBL] [Abstract][Full Text] [Related]
16. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up. Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400 [TBL] [Abstract][Full Text] [Related]
17. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. Hricik DE; Seliga RM; Fleming-Brooks S; Bartucci MR; Schulak JA Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637 [TBL] [Abstract][Full Text] [Related]